Roberta Bernardini
Overview
Explore the profile of Roberta Bernardini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zoziuk M, Colizzi V, Krysenko P, Mattei M, Bernardini R, Zanzotto F, et al.
Curr Issues Mol Biol
. 2025 Jan;
47(1).
PMID: 39852157
Determining the relationships between miRNA expression, target genes, and cancer development is critical to cancer research. The possibility of correlating miRNA expression with plant or artificial ones provides prerequisites for...
2.
Lacconi V, Massimiani M, Antonello G, Gasco P, Bernardini R, Ferrari C, et al.
Front Toxicol
. 2025 Jan;
6():1508598.
PMID: 39839550
Solid lipid nanoparticles (SLNs) have gained interest as drug delivery carriers due to their efficient cellular internalization and increased therapeutic effect of the loaded drug, with minimal side effects. Although...
3.
Fiaschini N, Hanieh P, Ariaudo D, Cimino R, Abbate C, Romano E, et al.
Pharmaceutics
. 2025 Jan;
16(12.
PMID: 39771571
Background/objectives: This study aimed to develop a novel nanotechnological slow-release drug delivery platform based on hyaluronic acid Microsponge (MSP) for the subcutaneous administration of methotrexate (MTX) in the treatment of...
4.
Exertier C, Antonelli L, Fiorillo A, Bernardini R, Colotti B, Ilari A, et al.
Cancers (Basel)
. 2024 Aug;
16(16).
PMID: 39199583
SOluble Resistance-related Calcium-binding proteIN (sorcin) earned its name due to its co-amplification with ABCB1 in multidrug-resistant cells. Initially thought to be an accidental consequence of this co-amplification, recent research indicates...
5.
Piastra V, Ganci F, Sacconi A, Pranteda A, Allegretti M, Bernardini R, et al.
J Exp Clin Cancer Res
. 2024 Aug;
43(1):234.
PMID: 39164711
Background: Colorectal cancer (CRC) is the third most common type of cancer and the second leading cause of cancer-related deaths worldwide, with a survival rate near to 10% when diagnosed...
6.
Marrocco F, Falvo E, Mosca L, Tisci G, Arcovito A, Reccagni A, et al.
Cell Death Dis
. 2024 Apr;
15(4):262.
PMID: 38615026
Gliomas are among the most fatal tumors, and the available therapeutic options are very limited. Additionally, the blood-brain barrier (BBB) prevents most drugs from entering the brain. We designed and...
7.
Vesci L, Tundo G, Soldi S, Galletti S, Stoppoloni D, Bernardini R, et al.
Nutrients
. 2024 Apr;
16(7).
PMID: 38612971
Crohn's and ulcerative colitis are common conditions associated with inflammatory bowel disease as well as intestinal flora and epithelial barrier dysfunction. A novel fermented (AL0035) herein assayed in a trinitro...
8.
Campagnolo L, Lacconi V, Bernardini R, Viziano A, Pietroiusti A, Ippoliti L, et al.
Front Toxicol
. 2024 Jan;
6:1323681.
PMID: 38283866
Zinc oxide nanoparticles (ZnO NPs) have been engineered and are largely used in material science and industry. This large and increasing use justifies a careful study about the toxicity of...
9.
Bernardini R, Tengattini S, Li Z, Piubelli L, Bavaro T, Modolea A, et al.
Biol Direct
. 2024 Jan;
19(1):11.
PMID: 38268026
Background: To create a dual-acting vaccine that can fight against tuberculosis, we combined antigenic arabino-mannan analogues with the Ag85B protein. To start the process, we studied the impact of modifying...
10.
Pranteda A, Piastra V, Serra M, Bernardini R, Lo Sardo F, Carpano S, et al.
Biomed Pharmacother
. 2023 Sep;
167:115480.
PMID: 37713993
Colorectal cancer (CRC) patients with BRAF mutations develop resistance to BRAF inhibitors at a very early stage. Understanding the molecular mechanisms involved in BRAF inhibitor resistance is critical for the...